CRVO CervoMed Inc.
Healthcare$3.05-0.33%ClosedMarket Cap: $28.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.67
P/S
87.83
EV/EBITDA
-0.66
DCF Value
$0.80
FCF Yield
-97.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-9642.1%
Net Margin
-9311.6%
ROE
-136.1%
ROA
-198.7%
ROIC
-242.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-8.1M | $-8.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-8.3M | $-8.1M | $— | — |
| FY null | $0.00 | NaN% | $-28.3M | $-27.0M | $— | — |
| Q3 null | $322.6K | 100.0% | $-8.0M | $-7.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-6.6M | $-6.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.3M | $-4.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-7.2M | $-6.7M | $— | — |
| FY null | $0.00 | NaN% | $-18.2M | $-16.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-5.4M | $-4.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.0M | $-2.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.6M | $-2.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-2.5M | $-2.4M | $-0.42 | — |